Reduced intravenous glutathione in the treatment of early parkinson's disease
- 1 October 1996
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 20 (7) , 1159-1170
- https://doi.org/10.1016/s0278-5846(96)00103-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaAnnals of Neurology, 1994
- Evidence for Transcapillary Transport of Reduced Glutathione in Vascular Perfused Guinea-Pig BrainBiochemical and Biophysical Research Communications, 1994
- Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's diseaseNeurology, 1993
- New insights into the cause of Parkinson's diseaseNeurology, 1992
- Selegiline as initial treatment in de novo parkinsonian patientsNeurology, 1992
- Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian BrainsJournal of Neurochemistry, 1989
- The protective influence of the locus ceruleus on the blood‐brain barrierAnnals of Neurology, 1984
- Parkinson's disease: A disorder due to nigral glutathione deficiency?Neuroscience Letters, 1982
- Glutathione and Related γ-Glutamyl Compounds: Biosynthesis and UtilizationAnnual Review of Biochemistry, 1976
- Treatment of Parkinsonism With LevodopaArchives of Neurology, 1969